Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diluted Betadine vs Vancomycin for Cardiac Surgery Wound Infection Prevention
NCT05276687Phase 4Unknown
- Sponsor
- Assiut University
- Start
- Sep 2022
- Primary completion
- Mar 2024
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
01
Overview
Phase 4, randomised, open-label trial of povidone-iodine and vancomycin in surgical site infection (SSI), sponsored by Assiut University. Primary endpoints: Superficial sternal wound infection at 20 days and Deep sternal wound infection at 20 days. Status: unknown.
02
Drugs
povidone-iodinevancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT05276687.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05276687.